Phibro Animal Health Corporation

Phibro Animal Health Corporation

PAHC · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

35.97USD+0.51 (+1.44%)

Price History

Full chart

Market Stats

Previous Close35.46
Open35.69
Day Range35.15 – 36.40
52-Week Range28.04 – 59.64
Volume293.91K
Market Cap1.45B
P/E (TTM)14.17
Forward P/E13.83
EPS2.52
Dividend Yield1.39%
Beta0.47
50-Day Avg35.60
200-Day Avg41.40

About

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Daniel M. Bendheim J.D.
  • Employees2.60K
  • HeadquartersGlenpointe Centre East, Teaneck, NJ, United States, 07666-6712, USA
  • Websitehttps://www.pahc.com

Leadership

  • Mr. Jack Clifford BendheimExecutive Chairman · b. 1947
  • Mr. Daniel M. Bendheim J.D.CEO, President & Director · b. 1972
  • Mr. Glenn C. DavidChief Financial Officer · b. 1972
  • Mr. Larry L. MillerChief Operating Officer · b. 1964
  • Ms. Judith A. WeinsteinSenior VP, General Counsel & Corporate Secretary · b. 1969
  • Ms. Lisa Ann EscuderoSenior Vice President of Human Resources · b. 1962
  • Mr. Ramon FuenmayorPresident South America Region
  • Mr. Samson LiPresident of Asia Pacific Region · b. 1972
  • Mr. Todd ArmstrongPresident of North American Region
  • Mr. Michael GiambalvoPresident of PhibroChem and Ethanol Performance Group

Financials

Income Statement

Currency: USD2000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue323.00M319.70M328.70M337.80M354.40M364.40M398.40M453.00M511.40M537.10M594.20M618.33M654.10M653.15M691.90M748.59M751.50M764.30M820.00M828.00M800.35M833.35M942.26M977.89M1.02B1.30B1.52B
Growth (%)--1.02%+2.82%+2.77%+4.91%+2.82%+9.33%+13.70%+12.89%+5.03%+10.63%+4.06%+5.78%-0.15%+5.93%+8.19%+0.39%+1.70%+7.29%+0.98%-3.34%+4.12%+13.07%+3.78%+4.07%+27.37%+17.12%
Cost of Revenue249.60M250.30M247.40M248.60M265.20M293.10M307.30M341.80M389.70M407.50M439.50M471.67M489.96M474.19M484.10M512.22M512.50M516.00M553.10M563.40M543.47M561.97M656.86M679.65M704.59M896.27M1.01B
Gross Profit73.40M69.40M81.30M89.20M89.20M71.30M91.10M111.20M121.70M129.60M154.70M146.66M164.14M178.96M207.80M236.37M239.00M248.30M266.90M264.60M256.88M271.38M285.40M298.24M313.09M399.94M511.71M
Gross Margin22.72%21.71%24.73%26.41%25.17%19.57%22.87%24.55%23.80%24.13%26.04%23.72%25.09%27.40%30.03%31.58%31.80%32.49%32.55%31.96%32.10%32.56%30.29%30.50%30.77%30.85%33.71%
Operating Expense57.70M64.00M70.70M63.30M45.50M66.90M68.10M90.10M92.40M88.20M101.90M105.43M114.81M122.23M144.00M148.70M153.30M150.40M168.00M191.30M187.69M196.51M206.41M226.39M259.78M289.48M313.28M
Operating Income15.70M5.40M10.60M25.90M43.70M4.40M23.00M21.10M29.30M41.40M52.80M41.24M49.33M56.73M63.80M87.67M85.70M97.90M98.90M73.30M69.19M74.87M78.99M71.85M53.31M110.47M198.44M
Operating Margin4.86%1.69%3.22%7.67%12.33%1.21%5.77%4.66%5.73%7.71%8.89%6.67%7.54%8.69%9.22%11.71%11.40%12.81%12.06%8.85%8.65%8.98%8.38%7.35%5.24%8.52%13.07%
EBITDA11.67M-22.59M-42.34M-14.21M10.76M-28.79M-26.51M-22.88M-22.10M-48.30M12.80M43.40M66.34M72.64M60.84M114.92M117.06M123.90M125.84M112.75M101.58M110.21M117.13M106.03M69.06M146.85M236.46M
EBITDA Margin3.61%-7.07%-12.88%-4.21%3.04%-7.90%-6.65%-5.05%-4.32%-8.99%2.15%7.02%10.14%11.12%8.79%15.35%15.58%16.21%15.35%13.62%12.69%13.23%12.43%10.84%6.79%11.33%15.58%
Net Income10.10M-14.90M-51.80M-17.60M12.90M-22.10M-13.10M-6.70M2.20M-8.30M42.10M-12.92M6.98M24.89M-3.10M60.28M82.70M64.60M64.90M54.70M33.55M54.38M49.17M32.61M2.42M48.26M99.72M
Net Income Margin3.13%-4.66%-15.76%-5.21%3.64%-6.06%-3.29%-1.48%0.43%-1.55%7.09%-2.09%1.07%3.81%-0.45%8.05%11.00%8.45%7.91%6.61%4.19%6.53%5.22%3.33%0.24%3.72%6.57%
R&D1.56M2.95M5.27M4.63M5.08M5.57M-4.65M5.66M5.95M--7.19M6.64M8.21M9.51M11.03M9.44M10.00M12.08M13.74M17.76M20.83M24.39M29.19M23.73M-
R&D as % of Total Revenue0.48%0.92%1.60%1.37%1.43%1.53%-1.03%1.11%1.11%--1.10%1.02%1.19%1.27%1.47%1.24%1.22%1.46%1.72%2.13%2.21%2.49%2.87%1.83%-
Interest Expense14.20M17.70M17.70M17.40M20.60M26.90M32.60M27.30M26.90M43.40M33.10M34.59M35.70M35.77M33.00M14.55M16.85M14.90M11.90M13.68M14.30M10.40M12.10M17.95M21.97M33.25M47.60M
Interest Expense % of Total Revenue4.40%5.54%5.38%5.15%5.81%7.38%8.18%6.03%5.26%8.08%5.57%5.59%5.46%5.48%4.77%1.94%2.24%1.95%1.45%1.65%1.79%1.25%1.28%1.84%2.16%2.57%3.14%

Balance Sheet

Currency: USD2000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets258.50M330.00M296.40M274.30M241.40M253.10M248.30M271.90M325.07M361.63M--440.91M474.14M472.32M493.32M610.37M623.40M671.68M726.67M784.10M841.33M931.70M971.40M982.18M1.36B1.50B
Total Liabilities226.80M326.60M357.60M358.90M305.20M298.00M332.00M359.90M363.47M415.50M--529.14M543.08M457.17M463.69M519.89M472.24M486.73M510.66M595.90M602.80M669.26M688.89M725.54M1.08B1.12B
Total Equity31.60M3.40M-61.20M-84.50M-63.80M-44.90M-83.80M-88.00M-38.39M-53.88M---88.23M-68.94M15.15M29.63M90.48M151.16M184.95M216.01M188.20M238.53M262.44M282.51M256.64M285.68M385.48M
Cash2.40M14.80M6.40M11.20M5.60M13.00M8.70M12.00M6.99M13.52M--53.90M27.37M11.82M29.22M33.60M56.08M29.17M57.57M36.34M50.21M74.25M41.28M70.61M68.04M61.42M
Total Debt150.50M172.20M185.90M141.90M169.90M184.70M218.30M240.60M----350.12M365.60M289.39M289.52M352.71M313.14M312.38M326.18M410.72M426.71M470.48M509.97M525.46M761.55M788.77M
Net Debt148.10M157.40M179.50M130.70M164.30M171.70M209.60M228.60M----296.22M338.24M277.57M260.30M319.11M257.06M283.21M268.60M374.38M376.49M396.24M468.69M454.85M693.51M727.35M

Cash Flow

Currency: USD2000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-7.91M13.14M-4.75M34.66M2.86M-6.16M810.00K-4.73M-40.06M-4.68M31.99M415.00K-712.00K68.70M37.22M98.40M70.01M47.17M59.35M48.31M31.65M13.31M87.59M80.12M68.95M
Investing Cash Flow-4.06M-40.15M-17.36M-3.97M9.07M20.00K-5.30M-11.93M---19.46M-17.74M-37.34M-19.41M-34.46M-82.79M-21.90M-84.61M-14.13M-120.39M-18.58M-22.58M-74.02M-48.19M-288.69M-71.45M
Financing Cash Flow11.35M39.90M13.68M-26.38M-17.78M14.25M-540.00K19.86M34.22M29.10M10.16M-8.22M10.88M4.78M-15.35M50.38M-53.74M-11.78M-4.11M40.94M-17.00M16.34M26.99M-6.77M207.13M-6.56M
Capital Expenditure22.60M6.61M8.52M8.51M6.13M7.49M15.09M10.62M19.83M17.75M21.64M14.82M19.95M19.85M20.06M36.35M20.90M18.55M29.89M34.05M29.32M37.04M51.79M41.24M38.29M59.09M
Free Cash Flow-30.51M6.53M-13.27M26.15M-3.27M-13.65M-14.28M-15.35M---26.32M17.16M-19.53M-20.56M48.65M866.00K77.50M51.46M17.28M25.30M18.99M-5.39M-38.48M46.36M41.83M9.87M
Dividends Paid----------50.00M-3.00M25.00M15.60M15.71M15.83M16.07M18.59M19.42M19.43M19.44M19.44M19.44M19.45M19.46M
FCF to OCF385.71%49.70%279.37%75.45%-114.34%221.59%-1762.96%324.52%--562.29%53.66%-4706.51%2887.36%70.81%2.33%78.76%73.51%36.63%42.63%39.30%-17.05%-289.14%52.92%52.21%14.31%
Dividend Paid to FCF-----------190.01%--15.36%-121.61%32.06%1813.86%20.42%31.23%107.61%76.74%102.34%-360.37%-50.52%41.94%46.49%197.27%

Earnings

Report DateMay 13, 2014Sep 16, 2014Nov 11, 2014Feb 10, 2015May 11, 2015Sep 9, 2015Nov 9, 2015Feb 9, 2016May 9, 2016Aug 29, 2016Nov 9, 2016Feb 6, 2017May 8, 2017Aug 30, 2017Nov 6, 2017Feb 5, 2018May 7, 2018Aug 27, 2018Nov 6, 2018Feb 6, 2019May 6, 2019Aug 27, 2019Nov 4, 2019Feb 3, 2020May 7, 2020Aug 26, 2020Nov 4, 2020Feb 3, 2021May 6, 2021Aug 25, 2021Nov 2, 2021Feb 9, 2022May 4, 2022Aug 24, 2022Nov 9, 2022Feb 8, 2023May 3, 2023Aug 30, 2023Nov 8, 2023Feb 7, 2024May 8, 2024Aug 28, 2024Nov 6, 2024Feb 5, 2025May 7, 2025Aug 27, 2025Nov 5, 2025Feb 4, 2026May 6, 2026Aug 26, 2026Nov 4, 2026
EPS Estimate0.410.390.350.350.360.380.410.400.410.380.360.350.340.330.370.390.440.420.410.430.430.360.240.290.340.220.230.280.320.310.290.330.350.380.270.300.340.380.230.280.290.330.250.450.520.520.590.670.710.720.77
EPS Actual0.360.220.510.350.410.440.440.390.380.400.360.340.420.390.380.350.480.460.390.410.390.330.190.340.380.170.270.340.340.320.250.370.330.360.210.340.290.380.140.330.310.410.350.540.630.570.730.870.760.85-
Surprise-12.20%-43.59%45.71%0.00%13.89%15.79%7.32%-2.50%-7.32%5.26%0.00%-2.86%23.53%18.18%2.70%-10.26%9.09%9.52%-4.88%-4.65%-9.30%-8.33%-20.83%17.24%11.76%-22.73%17.39%21.43%6.25%3.23%-13.79%12.12%-5.71%-5.26%-22.22%13.33%-14.71%0.00%-39.13%17.86%6.90%24.24%40.00%20.00%21.15%9.62%23.73%29.85%7.04%18.06%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.45B
Enterprise Value2.09B
Trailing P/E14.17
Forward P/E13.83
PEG Ratio1.68
Price / Sales0.95
Price / Book3.59
EPS2.52
Book Value9.50
Revenue (TTM)1.52B
Gross Profit (TTM)505.97M
EBITDA244.23M
Profit Margin6.57%
Operating Margin10.64%
Return on Equity29.72%
Return on Assets8.48%
Shares Outstanding21.11M
Shares Float20.91M
Beta0.47
Dividend Yield1.39%
Dividend Rate0.48
Payout Ratio14.95%

Analyst Ratings

Hold
Based on 4 analystsTarget 44.00
  • Hold
    2
  • Sell
    2

Ownership Breakdown

Institutions
103.98%
Insiders
0.87%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    3.25M8.01%
  • FMR Inc
    2.17M5.35%
  • State Street Corp
    950.03K2.34%
  • Millennium Management LLC
    936.70K2.31%
  • Vanguard Capital Management, LLC
    891.28K2.20%
  • Acadian Asset Management LLC
    617.07K1.52%
  • Geode Capital Management, LLC
    604.65K1.49%
  • Renaissance Technologies Corp
    576.74K1.42%
  • Dimensional Fund Advisors, Inc.
    531.09K1.31%
  • Vanguard Portfolio Management, LLC
    490.34K1.21%
  • Nuveen, LLC
    455.89K1.12%
  • Lord, Abbett & Co LLC
    397.71K0.98%
  • Morgan Stanley - Brokerage Accounts
    391.19K0.96%
  • Amvescap Plc.
    330.98K0.82%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    1.28M3.16%
  • Fidelity Low-Priced Stock
    787.20K1.94%
  • Vanguard MStar Total Stk Mkt Idx Invest
    659.63K1.62%
  • iShares Russell 2000 ETF
    540.55K1.33%
  • Strategic Advisers Fidelity US TtlStk
    400.44K0.99%
  • Lord Abbett Value Opportunities I
    343.78K0.85%

Dividends

20263×
0.12Sep 2, 20260.12Jun 3, 20260.12Mar 4, 2026
20254×
0.12Nov 26, 20250.12Sep 3, 20250.12Jun 4, 20250.12Mar 5, 2025
20244×
0.12Nov 27, 20240.12Sep 4, 20240.12Jun 6, 20240.12Mar 5, 2024
20234×
0.12Nov 28, 20230.12Sep 5, 20230.12Jun 6, 20230.12Feb 28, 2023
20224×
0.12Nov 29, 20220.12Sep 6, 20220.12May 31, 20220.12Mar 1, 2022
20214×
0.12Nov 23, 20210.12Aug 31, 20210.12Jun 1, 20210.12Mar 2, 2021
20201×
0.12Nov 24, 2020